Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pacific Edge Limited ( (PFGTF) ) just unveiled an announcement.
Westpac Banking Corporation has disclosed a reduction in its substantial holding in Pacific Edge Limited from 6.61% to 5.25% due to an increase in the issued capital of the company. This change reflects a shift in Westpac’s investment position, potentially impacting Pacific Edge’s shareholder composition and market perception.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company is known for its innovative cancer diagnostic products, which are aimed at improving patient outcomes and reducing healthcare costs.
For detailed information about PFGTF stock, go to TipRanks’ Stock Analysis page.